FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
dvm36011h
First generic drug for pruritus and cough conditions in dogs to be exhibited at VMX
Trimeprazine with Prednisolone Tablets, the generic equivalent of Temaril-P (Zoetis), will be displayed at this year’s ...
Psychology Today19h
Treatment of Addiction
Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...